Chronic urticaria: Difference between revisions
No edit summary |
|||
| Line 21: | Line 21: | ||
**[[Doxepin]] <ref> Simons FE, et al; Histamine and H1-antihistamines: celebrating a century of progress. PMID: 22035879 </ref> | **[[Doxepin]] <ref> Simons FE, et al; Histamine and H1-antihistamines: celebrating a century of progress. PMID: 22035879 </ref> | ||
**[[Mirtazapine]] | **[[Mirtazapine]] | ||
*Consider corticosteroids | |||
**[[methylprednisolone]] 125mg IV/IM OR [[prednisone]] 60mg PO | |||
==Disposition== | ==Disposition== | ||
Revision as of 14:56, 1 August 2019
Background
- Recurrent urticaria at least twice per week for 6 weeks [1]
- Often autoimmune etiology
Clinical Features
- Urticaria
Differential Diagnosis
Acute allergic reaction
- Allergic reaction/urticaria
- Anaphylaxis
- Angioedema
- Anxiety attack
- Asthma exacerbation
- Carcinoid syndrome
- Cold urticaria
- Contrast induced allergic reaction
- Scombroid
- Shock
- Transfusion reaction
Evaluation
- Rule out anaphylaxis
- Identify any causative agents
Management
- H1/H2 blockers
- 2nd line agents
- Consider corticosteroids
- methylprednisolone 125mg IV/IM OR prednisone 60mg PO
Disposition
- Discharge if no concern for anaphylaxis